TrialClinical and translational science2023

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects.

Min Young Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.